Mucopolysaccharidosis Type Vii
📧 Sign up to get email alerts when something new happens for Mucopolysaccharidosis Type Vii.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-12-23FDA Approved: MEPSEVII — Supplemental Application (Ultragenyx Pharmaceutical Inc.)
The FDA approved Ultragenyx's supplemental application for MEPSEVII (vestronidase alfa), approving updates to its labeling for the treatment…
-
FDA approval · 2019-12-06FDA Approved: MEPSEVII — Supplemental Application (Ultragenyx Pharmaceutical Inc.)
The FDA approved a supplemental application for Mepsevii (vestronidase alfa) submitted by Ultragenyx Pharmaceutical Inc.
-
FDA approval · 2017-11-15FDA Approved: MEPSEVII — Original Application (Ultragenyx Pharmaceutical Inc.)
The FDA approved Mepsevii (vestronidase alfa) as an original Biologics License Application for the treatment of mucopolysaccharidosis type V…